Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 32, Number 1—January 2026

Research Letter

Mycobacterium decipiens Infection in Patient Receiving Anti–TNF-α Therapy, France, 2024

Justin Charles-Antoine DestoopComments to Author , Corentin Poignon, William Danjou, Alexandre Bleibtreu, Valerie Pourcher, and Gentiane Monsel
Author affiliation: Pitié-Salpêtrière University Hospital, Paris, France (J.C.-A. Destoop, W. Danjou, A. Bleibtreu, V. Pourcher, G. Monsel); Dermatological Infectiology and Sexually Transmitted Infections Group of the French Society of Dermatology, Paris (J.C.-A. Destoop, G. Monsel); Sorbonne Université, Paris (C. Poignon); French National Institute of Health and Medical Research, Paris (C. Poignon, A. Bleibtreu, V. Pourcher)

Main Article

Figure

Cutaneous infection on the right knee before and after treatment from study of Mycobacterium decipiens infection in a patient treated with anti–tumor necrosis factor-α therapy, France, 2024. A) Before treatment: erythematous, exudative, budding lesion over the patella with multiple satellite nodules. B) After treatment: residual pigmented macular lesions, sometimes depressed, consistent with postinflammatory changes.

Figure. Cutaneous infection on the right knee before and after treatment from study of Mycobacterium decipiens infection in a patient treated with anti–tumor necrosis factor-α therapy, France, 2024. A) Before treatment: erythematous, exudative, budding lesion over the patella with multiple satellite nodules. B) After treatment: residual pigmented macular lesions, sometimes depressed, consistent with postinflammatory changes.

Main Article

Page created: December 24, 2025
Page updated: January 29, 2026
Page reviewed: January 29, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external